Cargando…
Retrospective nationwide study on the trends in first‐line antidiabetic medication for patients with type 2 diabetes in Japan
AIMS/INTRODUCTION: To investigate the national trend in the prescription of first‐line non‐insulin antidiabetic agents and total medical costs (TMCs) after prescribing the drug in Japanese patients with type 2 diabetes. MATERIALS AND METHODS: Using the National Database of Health Insurance Claims an...
Autores principales: | Bouchi, Ryotaro, Sugiyama, Takehiro, Goto, Atsushi, Imai, Kenjiro, Ihana‐Sugiyama, Noriko, Ohsugi, Mitsuru, Yamauchi, Toshimasa, Kadowaki, Takashi, Ueki, Kohjiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847136/ https://www.ncbi.nlm.nih.gov/pubmed/34309213 http://dx.doi.org/10.1111/jdi.13636 |
Ejemplares similares
-
Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID‐19 pandemic: A retrospective observational study
por: Terakawa, Aiko, et al.
Publicado: (2022) -
Influence of the COVID-19 Pandemic on Overall Physician Visits and Telemedicine Use Among Patients With Type 1 or Type 2 Diabetes in Japan
por: Yagome, Susumu, et al.
Publicado: (2022) -
Factors associated with the degree of glycemic deterioration among patients with type 2 diabetes who dropped out of diabetes care: A longitudinal analysis using medical claims and health checkup data in Japan
por: Ihana‐Sugiyama, Noriko, et al.
Publicado: (2021) -
Patient referral flow between physician and ophthalmologist visits for diabetic retinopathy screening among Japanese patients with diabetes: A retrospective cross‐sectional cohort study using the National Database
por: Ihana‐Sugiyama, Noriko, et al.
Publicado: (2023) -
Comparison of effectiveness and drug cost between dipeptidyl peptidase‐4 inhibitor and biguanide as the first‐line anti‐hyperglycaemic medication among Japanese working generation with type 2 diabetes
por: Ihana‐Sugiyama, Noriko, et al.
Publicado: (2019)